conductor

She told herself it was about quality. It was about something else entirely.

In pharma, the caution that protects patients becomes the fortress that protects identity.

Too valuable to promote. Too complex to replace. A different way to hold it.

The difference between strategy and stalling. One accepts it will be wrong and moves anyway.